Adding salmeterol to an inhaled corticosteroid reduces allergen-induced serum IL-5 and peripheral blood eosinophils

Journal of Allergy and Clinical Immunology

Volumn 116, Issue 5, 2005, Pages 1007-1013

  Koopmans, Julia G ^a   Lutter, René ^a   Jansen, Henk M ^a   Van Der Zee, Jaring S ^a,b  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

Anti inflammatory agents; Asthma; Bronchodilator agents; Inflammation; Sputum

Indexed keywords

ALBUMIN; ALLERGEN; ALPHA 2 MACROGLOBULIN; CORTICOSTEROID; EOSINOPHIL CATIONIC PROTEIN; FLUTICASONE; FLUTICASONE PROPIONATE PLUS SALMETEROL; INTERLEUKIN 5; INTERLEUKIN 8; MYELOPEROXIDASE;

ADULT; ALLERGIC ASTHMA; ARTICLE; BLOOD SAMPLING; BRONCHUS; CELL COUNT; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DISEASE MARKER; DOUBLE BLIND PROCEDURE; DRUG EFFECT; EOSINOPHIL; EOSINOPHILIA; FEMALE; HUMAN; HUMAN CELL; INTERMETHOD COMPARISON; LUNG FUNCTION TEST; MALE; OVARY INFLAMMATION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL; REACTION TIME; SINGLE DRUG DOSE; SPUTUM ANALYSIS; STATISTICAL SIGNIFICANCE; TREATMENT OUTCOME;

ADMINISTRATION, INHALATION; ALBUTEROL; ALLERGENS; ANDROSTADIENES; ASTHMA; BRONCHODILATOR AGENTS; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; DRUG THERAPY, COMBINATION; EOSINOPHILS; HUMANS; HYPERSENSITIVITY; INTERLEUKIN-5; LEUKOCYTE COUNT; TIME FACTORS;

EID: 27644449489     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaci.2005.08.016     Document Type: Article

References (37)

1. Global Initiative for Asthma (GINA) Global strategy for asthma management and prevention: NHLBI/WHO workshop report 2002 National Institutes of Health, National Heart Lung and Blood Institute Bethesda (MD) NIH Publication No. 02-3659
2. R.P. Schleimer, E.S. Schulman, D.W. MacGlashan Jr., S.P. Peters, E.C. Hayes, and G.K. Adams III Effects of dexamethasone on mediator release from human lung fragments and purified human lung mast cells J Clin Invest 71 1983 1830 1835
3. E. Dompeling, C.P. van Schayck, P.M. van Grunsven, C.L. van Herwaarden, R. Akkermans, and J. Molema Slowing the deterioration of asthma and chronic obstructive pulmonary disease observed during bronchodilator therapy by adding inhaled corticosteroids: a 4-year prospective study Ann Intern Med 118 1993 770 778
4. S. Shrewsbury, S. Pyke, and M. Britton Meta-analysis of increased dose of inhaled steroid or addition of salmeterol in symptomatic asthma (MIASMA) BMJ 320 2000 1368 1373
5. D.R. Taylor, and R.J. Hancox Interactions between corticosteroids and beta agonists Thorax 55 2000 595 602
6. M. Johnson Effects of beta2-agonists on resident and infiltrating inflammatory cells J Allergy Clin Immunol 110 2002 S282 S290
7. E. Pace, R. Gagliardo, M. Melis, S. La Grutta, M. Ferraro, and L. Siena Synergistic effects of fluticasone propionate and salmeterol on in vitro T-cell activation and apoptosis in asthma J Allergy Clin Immunol 114 2004 1216 1223
8. O. Eickelberg, M. Roth, R. Lorx, V. Bruce, J. Rudiger, and M. Johnson Ligand-independent activation of the glucocorticoid receptor by beta2-adrenergic receptor agonists in primary human lung fibroblasts and vascular smooth muscle cells J Biol Chem 274 1999 1005 1010
9. P.J. Barnes, S. Pedersen, and W.W. Busse Efficacy and safety of inhaled corticosteroids: new developments Am J Respir Crit Care Med 157 1998 S1 S53
10. A. Wallin, M. Sue-Chu, L. Bjermer, J. Ward, T. Sandstrom, and A. Lindberg Effect of inhaled fluticasone with and without salmeterol on airway inflammation in asthma J Allergy Clin Immunol 112 2003 72 78
11. X. Li, C. Ward, F. Thien, R. Bish, T. Bamford, and X. Bao An antiinflammatory effect of salmeterol, a long-acting beta(2) agonist, assessed in airway biopsies and bronchoalveolar lavage in asthma Am J Respir Crit Care Med 160 1999 1493 1499
12. K.S. Babu, and S.H. Arshad The role of allergy in the development of airway inflammation in children Paediatr Respir Rev 4 2003 40 46
13. T.A. Platts-Mills, and M.C. Carter Asthma and indoor exposure to allergens N Engl J Med 336 1997 1382 1384
14. P.J. Sterk, L.M. Fabbri, P.H. Quanjer, D.W. Cockcroft, P.M. O'Byrne, and S.D. Anderson Airway responsiveness: standardized challenge testing with pharmacological, physical and sensitizing stimuli in adults. Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Official Statement of the European Respiratory Society Eur Respir J Suppl 16 1993 53 83
15. A.M. Witteman, S.O. Stapel, G.J. Perdok, D.H. Sjamsoedin, H.M. Jansen, and R.C. Aalberse The relationship between RAST and skin test results in patients with asthma or rhinitis: a quantitative study with purified major allergens J Allergy Clin Immunol 97 1996 16 25
16. J.V. Fahy, H.A. Boushey, S.C. Lazarus, E.A. Mauger, R.M. Cherniack, and V.M. Chinchilli NHLBI Asthma Clinical Network. Safety and reproducibility of sputum induction in asthmatic subjects in a multicenter study Am J Respir Crit Care Med 163 2001 1470 1475
17. R.E. Nocker, T.A. Out, F.R. Weller, M.J. de Riemer, and H.M. Jansen van der Zee JS. Induced sputum and bronchoalveolar lavage as tools for evaluating the effects of inhaled corticosteroids in patients with asthma J Lab Clin Med 136 2000 39 49
18. C.M. Reimert, P. Venge, A. Kharazmi, and K. Bendtzen Detection of eosinophil cationic protein (ECP) by an enzyme-linked immunosorbent assay J Immunol Methods 138 1991 285 290
19. P. Bresser, T.A. Out, L. van Alphen, H.M. Jansen, and R. Lutter Airway inflammation in nonobstructive and obstructive chronic bronchitis with chronic haemophilus influenzae airway infection: comparison with noninfected patients with chronic obstructive pulmonary disease Am J Respir Crit Care Med 162 2000 947 952
20. L.A. McNamee, D.I. Fattah, T.J. Baker, S.K. Bains, and P.H. Hissey Production, characterisation and use of monoclonal antibodies to human interleukin-5 in an enzyme-linked immunosorbent assay J Immunol Methods 141 1991 81 88
21. R.E. Nocker, F.R. Weller, T.A. Out, M.J. de Riemer, H.M. Jansen, and J.S. Van Der Zee A double-blind study on the effect of inhaled corticosteroids on plasma protein exudation in asthma Am J Respir Crit Care Med 159 1999 1499 1505
22. E.J. Weersink, R. Aalbers, G.H. Koeter, H.F. Kauffman, J.G. De Monchy, and D.S. Postma Partial Inhibition of the early and late asthmatic response by a single dose of salmeterol Am J Respir Crit Care Med 150 1994 1262 1267
23. F.H. Krouwels, R.E. Nocker, M. Snoek, R. Lutter, J.S. van der Zee, and F.R. Weller Immunocytochemical and flow cytofluorometric detection of intracellular IL-4, IL-5 and IFN-gamma: applications using blood- and airway-derived cells J Immunol Methods 203 1997 89 101
24. H.C. Oettgen, and R.S. Geha IgE regulation and roles in asthma pathogenesis J Allergy Clin Immunol 107 2001 429 440
25. Y. Okayama, C. Petit-Frere, O. Kassel, A. Semper, D. Quint, and M.J. Tunon-de-Lara IgE-dependent expression of mRNA for IL-4 and IL-5 in human lung mast cells J Immunol 155 1995 1796 1808
26. P. Bradding, Y. Okayama, P.H. Howarth, M.K. Church, and S.T. Holgate Heterogeneity of human mast cells based on cytokine content J Immunol 155 1995 297 307
27. P.R. Butchers, C.J. Vardey, and M. Johnson Salmeterol: a potent and long-acting inhibitor of inflammatory mediator release from human lung Br J Pharmacol 104 1991 672 676
28. E.Y. Bissonnette, and A.D. Befus Anti-inflammatory effect of beta 2-agonists: inhibition of TNF-alpha release from human mast cells J Allergy Clin Immunol 100 1997 825 831
29. R. Gronneberg, and B. Lagerholm Histopathological support of antagonism of allergen-induced mast cell mediator release in human skin by a beta-2-agonist Allergy 41 1986 71 74
30. E. Hamelmann, A. Oshiba, J. Schwarze, K. Bradley, J. Loader, and G.L. Larsen Allergen-specific IgE and IL-5 are essential for the development of airway hyperresponsiveness Am J Respir Cell Mol Biol 16 1997 674 682
31. N.N. Jarjour, W.J. Calhoun, E.A. Kelly, G.J. Gleich, L.B. Schwartz, and W.W. Busse The immediate and late allergic response to segmental bronchopulmonary provocation in asthma Am J Respir Crit Care Med 155 1997 1515 1521
32. M.J. Van Der Veen, R.J. Van Neerven, E.C. De Jong, R.C. Aalberse, H.M. Jansen, and J.S. Van Der Zee The late asthmatic response is associated with baseline allergen-specific proliferative responsiveness of peripheral T lymphocytes in vitro and serum interleukin-5 Clin Exp Allergy 29 1999 217 227
33. E. Hamelmann, and E.W. Gelfand Role of IL-5 in the development of allergen-induced airway hyperresponsiveness Int Arch Allergy Immunol 120 1999 8 16
34. M.J. Leckie, A. ten Brinke, J. Khan, Z. Diamant, B.J. O'Connor, and C.M. Walls Effects of an interleukin-5 blocking monoclonal antibody on eosinophils, airway hyper-responsiveness, and the late asthmatic response Lancet 356 2000 2144 2148
35. P.T. Flood-Page, A.N. Menzies-Gow, A.B. Kay, and D.S. Robinson Eosinophil's role remains uncertain as anti-interleukin-5 only partially depletes numbers in asthmatic airway Am J Respir Crit Care Med 167 2003 199 204
36. L.Y. Liu, J.B. Sedgwick, M.E. Bates, R.F. Vrtis, J.E. Gern, and H. Kita Decreased expression of membrane IL-5 receptor alpha on human eosinophils, I: loss of membrane IL-5 receptor alpha on airway eosinophils and increased soluble IL-5 receptor alpha in the airway after allergen challenge J Immunol 169 2002 6452 6458
37. G.P. Currie, N.J. Syme-Grant, L.C. McFarlane, F.A. Carey, and B.J. Lipworth Effects of low dose fluticasone/salmeterol combination on surrogate inflammatory markers in moderate persistent asthma Allergy 58 2003 602 607